However, more recently, studies reported that IGFBP1 affects the prognosis and mortality of cardiovascular diseases in patients without diabetes and glucose intolerance [7–9], which might be due to an independent direct regulation of vascular endothelial cells (EC) and smooth muscle cells (SMC) [4]. The gene discussed is IGFBP1; the disease is diabetes mellitus.